Global X HealthTech ETF

Frequently Asked Questions About HEAL

What does HEAL invest in?

HEAL aims to focus on tech-driven innovation in the healthcare sector. As such, the fund seeks to provide exposure to firms looking to shape the future of healthcare by improving patient outcomes and driving medical breakthroughs. Companies around the world, including ADRS, that engage in healthcare analytics and software, smart medical devices, AI-enabled drug discovery, and tech-enabled consumer healthcare. The underlying index screens for companies that are found in FactSet industries identified by the index administrator as relating to healthcare technology and derive at least 50% of their revenue from one or more of the subthemes. Prior to April 1, 2025, the fund tracked a narrower index targeting telemedicine and digital health, the Solactive Telemedicine & Digital Health Index. The fund name was Global X Telemedicine & Digital Health ETF and traded using the ticker EDOC.

What is the expense ratio of HEAL?

Global X HealthTech ETF (HEAL) charges an expense ratio of 0.50%. This is the annual fee deducted from fund assets to cover management and operations.

How big is HEAL?

Global X HealthTech ETF (HEAL) manages $35.4M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation.

Is HEAL actively managed or an index fund?

HEAL is a passive index fund. It tracks a published benchmark by holding the constituents in their published weights. Index funds typically charge low expense ratios (HEAL's is 0.50%) because there's no security selection cost.

When was HEAL launched?

Global X HealthTech ETF (HEAL) launched in July 2020 and is managed by Global X.

How has HEAL performed?

HEAL's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.